Article Information
History
- April 14, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- 1Senior Fellow, Clinical Pharmacology Modelling & Simulation, GlaxoSmithKline Research and Development, Email: daren.j.austin{at}gsk.com, Phone: +447712 670097
- ↵*Materials and Correspondence
Correspondence and requests for materials should be addressed to daren.j.austin{at}gsk.com. Reprints and permissions information is available at www.nature.com/reprints.
Posted April 14, 2020.
Near- and forecasting the SARS-COV-2 epidemic requires a global view and multiple methods
